2023
DOI: 10.1002/jmv.29244
|View full text |Cite
|
Sign up to set email alerts
|

The potential of PCNA inhibition as a therapeutic strategy in cervical cancer

Sebastian O. Wendel,
Jazmine A. Snow,
Long Gu
et al.

Abstract: Cervical cancers are the fourth most common and most deadly cancer in women worldwide. Despite being a tremendous public health burden, few novel approaches to improve care for these malignancies have been introduced. We discuss the potential for proliferating cell nuclear antigen (PCNA) inhibition to address this need as well as the advantages and disadvantages for compounds that can therapeutically inhibit PCNA with a specific focus on cervical cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 77 publications
(153 reference statements)
0
1
0
Order By: Relevance
“…The proliferating cell nuclear antigen (PCNA) plays an important role in the initiation of cell proliferation (DNA replication and repairing), and it can be used to evaluate the cell proliferation status. 49,50 As seen in Fig. 6B, the positive rate of PCNA in the REPNs + US group was significantly lower, indicating that the tumor proliferation rate in the REPNs + US group had been strongly inhibited.…”
Section: Resultsmentioning
confidence: 85%
“…The proliferating cell nuclear antigen (PCNA) plays an important role in the initiation of cell proliferation (DNA replication and repairing), and it can be used to evaluate the cell proliferation status. 49,50 As seen in Fig. 6B, the positive rate of PCNA in the REPNs + US group was significantly lower, indicating that the tumor proliferation rate in the REPNs + US group had been strongly inhibited.…”
Section: Resultsmentioning
confidence: 85%